3.1 Prescription Requirements, Formats & Electronic Prescribing (EPCS)

Prescription Validity, Transmission, and EPCS

A prescription is valid only when an authorized practitioner issues it for a legitimate medical purpose while acting in the usual course of professional practice. Format alone never cures a scope or purpose defect. A pharmacist shares responsibility for controlled-substance legitimacy and must resolve material omissions and red flags before dispensing.

Required information

For a controlled substance, 21 CFR § 1306.05 requires the prescription to be dated and signed on the day issued and to contain the patient's full name and address; the practitioner's full name, address, and DEA registration number; and the drug name, strength, dosage form, quantity, directions, and refills if authorized. Schedule II prescriptions have no refills. Schedule III–V prescriptions may authorize no more than five refills within six months.

The regulation does not create a universal “quantity in both numerals and words” rule. Do not reject a prescription solely because the quantity is not spelled out unless another applicable requirement or genuine alteration concern applies. Some missing information may be obtained from reliable records or the practitioner where federal and state law permit annotation; a pharmacist may not use correction as a way to create authority, change the patient, forge a signature, or substitute a different controlled drug.

All Schedule II prescriptions issued together under the federal multiple-prescription rule bear the actual issuance date. Later prescriptions may contain an earliest-fill instruction; they are not postdated. A handwritten controlled-substance prescription requires the practitioner's manual signature. A compliant electronic controlled-substance prescription is signed and transmitted through the EPCS system.

Oral and facsimile prescriptions

Noncontrolled and Schedule III–V prescriptions may generally be communicated orally by an authorized practitioner or agent and reduced to the required record by an authorized pharmacy professional. A new oral prescription is not a technician function.

An oral Schedule II prescription is limited to a bona fide emergency under 21 CFR § 1306.11(d). The pharmacist limits quantity to the emergency period, immediately reduces the order to writing, and makes a reasonable effort to identify the caller. The practitioner must deliver or postmark the signed follow-up prescription within seven days; if it is not received, the pharmacist notifies DEA as required. Mississippi separately limits an emergency oral Schedule II quantity to no more than a 48-hour supply.

A faxed Schedule II prescription ordinarily allows preparation, with the original required before dispensing. Federal law permits the fax to serve as the original for a Schedule II narcotic compounded for direct parenteral administration to a home-infusion patient, any Schedule II drug for a long-term-care-facility resident, and a Schedule II narcotic for a hospice patient when the prescription is properly noted. Apply the exact exception, not a broad “hospital” or “distance” exception.

Medicaid tamper-resistant paper

Federal Medicaid payment rules require a written outpatient prescription to use tamper-resistant paper with at least one feature from each of three categories: preventing unauthorized copying, preventing erasure or modification, and preventing use of counterfeit forms. Electronic, faxed, and verbal prescriptions are not paper prescriptions. For an emergency fill on noncompliant paper, the pharmacy must obtain a compliant written prescription or verify the prescription by another permitted method within 72 hours for Medicaid payment purposes. This payment rule should not be misstated as making the order void for every patient and payer.

Electronic prescribing

DEA's EPCS regulations allow controlled-substance prescriptions to be created, signed, transmitted, received, and archived electronically through compliant applications. Core safeguards include practitioner identity proofing, controlled assignment of signing permissions, two-factor authentication from distinct categories, audit trails, and application certification or audit. The pharmacy must ensure the electronic record is preserved and readily retrievable for the applicable federal and Mississippi retention periods.

The federal SUPPORT Act electronic-prescribing requirement is directed to covered Schedule II–V controlled substances under Medicare Part D, with statutory and regulatory exceptions. It is not a universal Mississippi rule that automatically invalidates every paper, fax, or otherwise lawful controlled-substance prescription. A pharmacist receiving a non-electronic prescription should apply the dispensing laws and the particular e-prescribing program rule rather than inventing an enforcement duty.

Verification sequence

First verify the practitioner’s identity, license, scope, and DEA authority where needed. Second confirm legitimate medical purpose and patient relationship. Third check content and format. Fourth resolve omissions, alteration concerns, duplicate therapy, PMP information, and other red flags. Document material communications. Never dispense merely because software accepted the claim or an electronic signature appears valid.